Article
Precision Elimination: Proof-of-Concept In Silico Testing of a Novel Construct for Optimizing HIV-1 Eradication
2025-03-28
Abstract excerpt
<h4>Background: </h4> /Objectives: Human immunodeficiency virus type 1 (HIV-1) persists in individuals on combination antiretroviral therapy (cART) due to the existence of latent reservoirs that evade immune detection. Although shock-and-kill strategies utilizing latency-reversing agents (LRAs) aim to reactivate and eliminate these reservoirs, their effectiveness is limited by cART's lack of cytotoxicity, which me...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- df9204b2-ec68-5824-abf5-99908b240947
- DOI
- 10.20944/preprints202503.0071.v2
